Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive...

Area of Science:

• Oncology
• Translational Research
• Biomarker Discovery

Background:

• Bladder cancer exhibits significant heterogeneity, leading to distinct tumor subtypes.
• Accurate tumor subtyping is essential for predicting patient outcomes and tailoring treatment strategies.
• Current challenges include reproducible subtyping for precise therapeutic decision-making.

Purpose of the Study:

• To underscore the importance of identifying bladder cancer subtypes for personalized medicine.
• To highlight the need for precise subtyping to guide perioperative therapy selection.
• To emphasize the role of subtyping in patient selection for bladder preservation approaches.

Main Methods:

• This study reviews the current understanding of bladder cancer heterogeneity.
• It emphasizes the necessity of reproducible tumor subtyping methodologies.
• The focus is on the application of subtyping in clinical decision-making.

Main Results:

• Tumor heterogeneity is the basis for diverse bladder cancer subtypes.
• Reproducible subtyping can predict specific patient outcomes, including therapy response.
• Identifying responsive subtypes is critical for bladder preservation.

Conclusions:

• Precise bladder cancer subtyping is crucial for effective perioperative therapy.
• Biomarker-driven trials are necessary to improve treatment precision.
• Subtyping facilitates personalized treatment plans and enhances bladder preservation success.